Celltrion receives U.S. FDA approval for STOBOCLO ® (denosumab-bmwo) and OSENVELT ® (denosumab-bmwo) biosimilars referencing PROLIA ® and XGEVA ®

[
Celltrion receives U.S. FDA approval for STOBOCLO ® (denosumab-bmwo) and OSENVELT ® (denosumab-bmwo) biosimilars referencing PROLIA ® and XGEVA ®
[og_img]
https://www.investing.com/news/press-releases/celltrion-receives-us-fda-approval-for-stoboclo–denosumabbmwo-and-osenvelt–denosumabbmwo-biosimilars-referencing-prolia–and-xgeva–93CH-3904546


Investing.com